Status: Recruiting
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants with Heart Failure with Preserved Ejection Fraction (HFpEF)
Participants needed: 42
Trial details
Phase: Phase 1Age: 50+Biological sex: AllType: InterventionalSponsor: Vasa TherapeuticsUpdated: Apr 9, 2026Locations: 21
Eligibility criteria
Males or females ≥ 50 years of age at the time of signing the informed consent. [+10]
Female trial participant who is pregnant or breastfeeding. [+11]